Readouts from Novo Nordisk and Viking Therapeutics at AASLD 2024 strengthen the argument for GLP-1 therapies as an emerging ...

The pharmaceutical companies behind Ozempic, Wegovy and other weight-loss meds push to prevent compounding pharmacies from ...

T. Rowe Price held its 42nd annual global market outlook press briefing today, featuring a panel of the firm's investment experts sharing their forecasts for the 2025 global financial markets.